Skip to main content
. 2023 Sep 19;13:15461. doi: 10.1038/s41598-023-42788-6

Figure 2.

Figure 2

The proportion of progression (newly diagnosed or worsened severity) in non-alcoholic fatty liver disease (NAFLD) after menopausal hormone therapy (MHT) based on route of estrogen administration. P value based on chi-square test.